Authors:
Gaynor, ER
Unger, JM
Miller, TP
Grogan, TM
White, LA
Mills, GM
Balcerzak, SP
Varterasian, M
LeBlanc, M
Fisher, RI
Citation: Er. Gaynor et al., Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group study, J CL ONCOL, 19(3), 2001, pp. 750-755
Authors:
Press, OW
LeBlanc, M
Lichter, AS
Grogan, TM
Unger, JM
Wasserman, TH
Gaynor, ER
Peterson, BA
Miller, TP
Fisher, RI
Citation: Ow. Press et al., Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease, J CL ONCOL, 19(22), 2001, pp. 4238-4244
Authors:
Whitehead, RP
Unger, JM
Flaherty, LE
Eckardt, JR
Taylor, SA
Didolkar, MS
Samlowski, W
Sondak, VK
Citation: Rp. Whitehead et al., Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy - A Southwest Oncology Group study, INV NEW DR, 19(3), 2001, pp. 239-243
Authors:
Unger, JM
Flaherty, LE
Liu, PY
Albain, KS
Sondak, VK
Citation: Jm. Unger et al., Gender and other survival predictors in patients with metastatic melanoma on southwest oncology group trials, CANCER, 91(6), 2001, pp. 1148-1155
Authors:
Fisher, RI
Dana, BW
LeBlanc, M
Kjeldsberg, C
Forman, JD
Unger, JM
Balcerzak, SP
Gaynor, ER
Roy, V
Miller, T
Citation: Ri. Fisher et al., Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: Results of the Southwest Oncology Group randomized phase III study 8809, J CL ONCOL, 18(10), 2000, pp. 2010-2016
Authors:
Margolin, KA
Liu, PY
Unger, JM
Fletcher, WS
Flaherty, LE
Urba, WJ
Hersh, EM
Hutchins, LE
Sosman, JA
Smith, JW
Weiss, GR
Sondak, VK
Citation: Ka. Margolin et al., Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial, J CANC RES, 125(5), 1999, pp. 292-296
Authors:
Hutchins, LF
Unger, JM
Crowley, JJ
Coltman, CA
Albain, KS
Citation: Lf. Hutchins et al., Underrepresentation of patients 65 years of age or older in cancer-treatment trials., N ENG J MED, 341(27), 1999, pp. 2061-2067
Citation: Jm. Unger et al., Cross-sectional versus longitudinal estimates of cognitive change in nondemented older people: A CERAD study, J AM GER SO, 47(5), 1999, pp. 559-563
Authors:
Flaherty, LE
Unger, JM
Liu, PY
Mertens, WC
Sondak, VK
Citation: Le. Flaherty et al., Metastatic melanoma from in intraocular primary tumors - Southwest Oncology Group experience in phase II advanced melanoma clinical trials, AM J CL ONC, 21(6), 1998, pp. 568-572